Compile Data Set for Download or QSAR
Report error Found 18 Enz. Inhib. hit(s) with all data for entry = 2101
TargetCathepsin K(Human)
GrÜNenthal

US Patent
LigandPNGBDBM352414(US9802947, Compound Example 2 | N ((S)-2-((3aS,6S,...)
Affinity DataKi:  0.700nMAssay Description:Recombinant human cathepsins (CatS, CatK, CatL, CatB) were purchased from a Enzo Life Sciences. All assays were carried out in 96-well format using a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/1/2019
Entry Details
US Patent

TargetCathepsin K(Human)
GrÜNenthal

US Patent
LigandPNGBDBM352420(US9802947, Compound Example 8 | N ((S)-2-((3aS,6S,...)
Affinity DataKi:  0.800nMAssay Description:Recombinant human cathepsins (CatS, CatK, CatL, CatB) were purchased from a Enzo Life Sciences. All assays were carried out in 96-well format using a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/1/2019
Entry Details
US Patent

TargetCathepsin K(Human)
GrÜNenthal

US Patent
LigandPNGBDBM352413(US9802947, Compound Example 1 | N ((S)-2-((3aS,6S,...)
Affinity DataKi:  1.5nMAssay Description:Recombinant human cathepsins (CatS, CatK, CatL, CatB) were purchased from a Enzo Life Sciences. All assays were carried out in 96-well format using a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/1/2019
Entry Details
US Patent

TargetCathepsin K(Human)
GrÜNenthal

US Patent
LigandPNGBDBM352416(US9802947, Compound Example 4 | N ((S)-2-((3aS,6S,...)
Affinity DataKi:  1.80nMAssay Description:Recombinant human cathepsins (CatS, CatK, CatL, CatB) were purchased from a Enzo Life Sciences. All assays were carried out in 96-well format using a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/1/2019
Entry Details
US Patent

TargetCathepsin K(Human)
GrÜNenthal

US Patent
LigandPNGBDBM352415(US9802947, Compound Example 3 | N ((S)-2-((3aS,6S,...)
Affinity DataKi:  2.10nMAssay Description:Recombinant human cathepsins (CatS, CatK, CatL, CatB) were purchased from a Enzo Life Sciences. All assays were carried out in 96-well format using a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/1/2019
Entry Details
US Patent

TargetCathepsin K(Human)
GrÜNenthal

US Patent
LigandPNGBDBM352417(US9802947, Compound Example 5 | N ((S)-2-((3aS,6S,...)
Affinity DataKi:  2.10nMAssay Description:Recombinant human cathepsins (CatS, CatK, CatL, CatB) were purchased from a Enzo Life Sciences. All assays were carried out in 96-well format using a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/1/2019
Entry Details
US Patent

TargetCathepsin K(Human)
GrÜNenthal

US Patent
LigandPNGBDBM352418(US9802947, Compound Example 6 | N ((S)-2-((3aS,6S,...)
Affinity DataKi:  3.10nMAssay Description:Recombinant human cathepsins (CatS, CatK, CatL, CatB) were purchased from a Enzo Life Sciences. All assays were carried out in 96-well format using a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/1/2019
Entry Details
US Patent

TargetCathepsin K(Human)
GrÜNenthal

US Patent
LigandPNGBDBM352419(US9802947, Compound Example 7 | N ((S)-2-((3aS,6S,...)
Affinity DataKi:  5.30nMAssay Description:Recombinant human cathepsins (CatS, CatK, CatL, CatB) were purchased from a Enzo Life Sciences. All assays were carried out in 96-well format using a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/1/2019
Entry Details
US Patent

TargetCathepsin K(Human)
GrÜNenthal

US Patent
LigandPNGBDBM352421(US9802947, Example C1 (ex. 17 of WO2009/112839) | ...)
Affinity DataKi:  14.8nMAssay Description:Recombinant human cathepsins (CatS, CatK, CatL, CatB) were purchased from a Enzo Life Sciences. All assays were carried out in 96-well format using a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/1/2019
Entry Details
US Patent

TargetCathepsin S(Human)
GrÜNenthal

US Patent
LigandPNGBDBM352416(US9802947, Compound Example 4 | N ((S)-2-((3aS,6S,...)
Affinity DataKi:  39.8nMAssay Description:Recombinant human cathepsins (CatS, CatK, CatL, CatB) were purchased from a Enzo Life Sciences. All assays were carried out in 96-well format using a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/1/2019
Entry Details
US Patent

TargetCathepsin S(Human)
GrÜNenthal

US Patent
LigandPNGBDBM352421(US9802947, Example C1 (ex. 17 of WO2009/112839) | ...)
Affinity DataKi:  82.4nMAssay Description:Recombinant human cathepsins (CatS, CatK, CatL, CatB) were purchased from a Enzo Life Sciences. All assays were carried out in 96-well format using a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/1/2019
Entry Details
US Patent

TargetCathepsin S(Human)
GrÜNenthal

US Patent
LigandPNGBDBM352415(US9802947, Compound Example 3 | N ((S)-2-((3aS,6S,...)
Affinity DataKi:  110nMAssay Description:Recombinant human cathepsins (CatS, CatK, CatL, CatB) were purchased from a Enzo Life Sciences. All assays were carried out in 96-well format using a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/1/2019
Entry Details
US Patent

TargetCathepsin S(Human)
GrÜNenthal

US Patent
LigandPNGBDBM352413(US9802947, Compound Example 1 | N ((S)-2-((3aS,6S,...)
Affinity DataKi:  151nMAssay Description:Recombinant human cathepsins (CatS, CatK, CatL, CatB) were purchased from a Enzo Life Sciences. All assays were carried out in 96-well format using a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/1/2019
Entry Details
US Patent

TargetCathepsin S(Human)
GrÜNenthal

US Patent
LigandPNGBDBM352420(US9802947, Compound Example 8 | N ((S)-2-((3aS,6S,...)
Affinity DataKi:  160nMAssay Description:Recombinant human cathepsins (CatS, CatK, CatL, CatB) were purchased from a Enzo Life Sciences. All assays were carried out in 96-well format using a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/1/2019
Entry Details
US Patent

TargetCathepsin S(Human)
GrÜNenthal

US Patent
LigandPNGBDBM352418(US9802947, Compound Example 6 | N ((S)-2-((3aS,6S,...)
Affinity DataKi:  174nMAssay Description:Recombinant human cathepsins (CatS, CatK, CatL, CatB) were purchased from a Enzo Life Sciences. All assays were carried out in 96-well format using a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/1/2019
Entry Details
US Patent

TargetCathepsin S(Human)
GrÜNenthal

US Patent
LigandPNGBDBM352419(US9802947, Compound Example 7 | N ((S)-2-((3aS,6S,...)
Affinity DataKi:  263nMAssay Description:Recombinant human cathepsins (CatS, CatK, CatL, CatB) were purchased from a Enzo Life Sciences. All assays were carried out in 96-well format using a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/1/2019
Entry Details
US Patent

TargetCathepsin S(Human)
GrÜNenthal

US Patent
LigandPNGBDBM352414(US9802947, Compound Example 2 | N ((S)-2-((3aS,6S,...)
Affinity DataKi:  308nMAssay Description:Recombinant human cathepsins (CatS, CatK, CatL, CatB) were purchased from a Enzo Life Sciences. All assays were carried out in 96-well format using a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/1/2019
Entry Details
US Patent

TargetCathepsin S(Human)
GrÜNenthal

US Patent
LigandPNGBDBM352417(US9802947, Compound Example 5 | N ((S)-2-((3aS,6S,...)
Affinity DataKi:  355nMAssay Description:Recombinant human cathepsins (CatS, CatK, CatL, CatB) were purchased from a Enzo Life Sciences. All assays were carried out in 96-well format using a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/1/2019
Entry Details
US Patent